Global Ltd Gull Net Worth

The estimated Net Worth of Global Ltd Gull is at least $643 Milhão dollars as of 1 February 2019. Global Gull owns over 30,000 units of Usana Health Sciences Inc stock worth over $367,790,090 and over the last 10 years Global sold USNA stock worth over $275,156,427.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Global Gull USNA stock SEC Form 4 insiders trading

Global has made over 69 trades of the Usana Health Sciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Global sold 30,000 units of USNA stock worth $3,464,700 on 1 February 2019.

The largest trade Global's ever made was selling 360,827 units of Usana Health Sciences Inc stock on 1 December 2017 worth over $40,632,728. On average, Global trades about 41,639 units every 20 days since 2015. As of 1 February 2019 Global still owns at least 9,865,614 units of Usana Health Sciences Inc stock.

You can see the complete history of Global Gull stock trades at the bottom of the page.

What's Global Gull's mailing address?

Global's mailing address filed with the SEC is PO BOX N-4899, 2/F BAHAMAS FINANCIAL CTR, SHIRLEY & CHARLOTTE STREETS, NASSAU, C5, BH1-1000.

Insiders trading at Usana Health Sciences Inc

Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull, eMyron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.

What does Usana Health Sciences Inc do?

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su

Complete history of Global Gull stock trades at Usana Health Sciences Inc

Usana Health Sciences Inc executives and stock owners

Usana Health Sciences Inc executives and other stock owners filed with the SEC include:

• Kevin Guest,
  Chairman of the Board, Chief Executive Officer
• Jim Brown,
  President
• Kevin G. Guest,
  Chairman & CEO
• G Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Field Development Officer
• Walter Noot,
  Chief Operating Officer
• Jim Brown,
  Pres
• Daniel Macuga,
  Chief Communications and Marketing Officer
• G. Douglas Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Sales Officer
• Walter Noot,
  Chief Operating Officer
• Paul Jones,
  Chief Leadership Development Officer
• Peggie Pelosi,
  Independent Director
• Gilbert Fuller,
  Lead Independent Director
• Robert Anciaux,
  Senior Director
• Frederic Winssinger,
  Independent Director
• Feng Peng,
  Independent Director
• Timothy Wood,
  Independent Director
• Dr. Myron W. Wentz,
  Founder & Chairman Emeritus
• John Fleming,
  Director
• Brent Neidig,
  Chief Officer and Managing Director of China
• P. Joshua Foukas,
  Chief Legal Officer, General Counsel and Corporate Secretary
• Robert Sinnott,
  Chief Scientific Officer
• P. Joshua Foukas,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Patrique Richards,
  Exec. Director of Investor Relations & Bus. Devel.
• Dr. John Cuomo,
  Exec. Director of Product Devel. & Technology
• J Scott Nixon,
  Director
• Myron W Gull Global Ltd Wentz,
  
• Robert Auciaux,
  
• Global Ltd Gull,
  10% owner
• Myron W Wentz,
  CEO
• Deborah Woo,
  E.V.P. of Sales
• Donald R. Williams,
  Director
• Dave Wentz,
  President
• James Bramble,
  
• Jerry G Mcclain,
  Director
• Denis E Waitley,
  Director
• Roy Truett,
  Chief Information Officer
• Doug Braun,
  Chief Marketing Officer
• Ronald S Poelman,
  Director
• Rick Stambaugh,
  Chief Information Officer
• Holdings Ltd Gull,
  10% owner
• Fred W Cooper,
  Vice President of Operations
• Jeffrey Yates,
  Chief Financial Officer
• Mark H Wilson,
  V.P. of Customer Relations
• Bradford Richardson,
  E.V.P. of Asia Pacific
• G Doug Iiekking,
  CHIEF FINANCIAL OFFICER
• Peter Benedict,
  CHIEF INFORMATION OFFICER
• Joshua Foukas,
  CHIEF LEGAL OFFICER
• Xia Ding,
  Director